Gender aspects in patients with angina and unobstructed coronary arteries

Clinical Research in Cardiology Supplements

Volumn 8, Issue SUPPL. 1, 2013, Pages 25-31

  Ong, Peter ^a   Athanasiadis, Anastasios ^a   Sechtem, Udo ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Angina pectoris; Coronary microvascular dysfunction; Gender; Unobstructed coronary arteries

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICORANDIL; NITRATE; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY; CORONARY ARTERY DISEASE; EXERCISE TEST; FOLLOW UP; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; MICROANGIOPATHY; MICROCIRCULATION; PRIORITY JOURNAL; PROGNOSIS; RESTING HEART RATE; RISK ASSESSMENT; STABLE ANGINA PECTORIS; THORAX PAIN; VASCULITIS;

EID: 84875526786     PISSN: 18610706     EISSN: 18610714     Source Type: Journal    
DOI: 10.1007/s11789-013-0058-x     Document Type: Article

References (61)

1. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, DeBacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE project group (2003) Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987-1003.
2. Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105: 310-315.
3. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL (2006) Task Force on the management of stable angina pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the task force on the management of stable angina pectoris of the European Society of Cardiology. Eur Heart J 27: 1341-1381.
4. Zaman MJ, Junghans C, Sekhri N, Chen R, Feder GS, Timmis AD, Hemingway H (2008) Presentation of stable angina pectoris among women and South Asian people. CMAJ 179: 659-667.
5. Pepine CJ, Abrams J, Marks RG, Morris JJ, Scheidt SS, Handberg E (1994) Characteristics of a contemporary population with angina pectoris. TIDES investigators. Am J Cardiol 74: 226-231.
6. D'Antono B, Dupuis G, Fortin C, Arsenault A, Burelle D (2006) Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects. Am Heart J 151: 813-819.
7. Billing E, Hjemdahl P, Rehnqvist N (1997) Psychosocial variables in female vs male patients with stable angina pectoris and matched healthy controls. Eur Heart J 18: 911-918.
8. Mark DB, Shaw L, Harrell FE Jr, Hlatky MA, Lee KL, Bengtson JR, McCants CB, Califf RM, Pryor DB (1991) Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 325: 849-853.
9. Kwok Y, Kim C, Grady D, Segal M, Redberg R (1999) Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 83: 660-666.
10. Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, Brindis RG, Douglas PS (2010) Low diagnostic yield of elective coronary angiography. N Engl J Med 362: 886-895.
11. Lanza GA, Crea F (2010) Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 121: 2317-2325.
12. Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, Sechtem U (2012) High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol 59: 655-662.
13. Kardasz I, De Caterina R (2007) Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update. J Intern Med 261: 330-348.
14. Yilmaz A, Sechtem U (2012) Angina pectoris in patients with normal coronary angiograms: current pathophysiological concepts and therapeutic options. Heart 98: 1020-1029.
15. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, van de Werf F, Aylward P, Topol EJ, Califf RM (1999) Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb investigators. N Engl J Med 341: 226-232.
16. Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U (2008) Coronary artery spasm as a frequent cause of acute coronary syndrome: the CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) study. J Am Coll Cardiol 52: 523-527.
17. Deshmukh A, Kumar G, Pant S, Rihal C, Murugiah K, Mehta JL (2012) Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J 164: 66-71.
18. Agewall S, Daniel M, Eurenius L, Ekenbäck C, Skeppholm M, Malmqvist K, Hofman-Bang C, Collste O, Frick M, Henareh L, Jernberg T, Tornvall P (2012) Risk factors for myocardial infarction with normal coronary arteries and myocarditis compared with myocardial infarction with coronary artery stenosis. Angiology 63(7): 500-503 doi: 10. 1177/0003319711429560.
19. Wang CH, Kuo LT, Hung MJ et al (2002) Coronary vasospasm as a possible cause of elevated cardiac troponin I in patients with acute coronary syndrome and insignificant coronary artery disease. Am Heart J 144: 275-281.
20. Kytö V, Saraste A, Voipio-Pulkki LM, Saukko P (2007) Incidence of fatal myocarditis: a population-based study in Finland. Am J Epidemiol 165: 570-574.
21. Schneider B, Athanasiadis A, Stöllberger C, Pistner W, Schwab J, Gottwald U, Schoeller R, Gerecke B, Hoffmann E, Wegner C, Sechtem U (2011) Gender differences in the manifestation of tako-tsubo cardiomyopathy. Int J Cardiol doi: 10. 1016/j. ijcard. 2011. 11. 027.
22. Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nakama Y, Kagawa E, Dai K, Ikenaga H (2010). Presentation of Tako-tsubo cardiomyopathy in men and women. Clin Cardiol 33: 42-45.
23. Reis SE, Holubkov R, Conrad Smith AJ, Kelsey SF, Sharaf BL, Reichek N, Rogers WJ, Merz CN, Sopko G, Pepine CJ (2001) WISE Investigators. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 141: 735-741.
24. Vermeltfoort IA, Raijmakers PG, Riphagen II, Odekerken DA, Kuijper AF, Zwijnenburg A, Teule GJ (2010) Definitions and incidence of cardiac syndrome X: review and analysis of clinical data. Clin Res Cardiol 99: 475-481.
25. Sueda S, Ochi N, Kawada H, Matsuda S, Hayashi Y, Tsuruoka T, Uraoka T (1999) Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol 83: 1186-1190.
26. Saraste A, Kytö V, Saraste M, Vuorinen T, Hartiala J, Saukko P (2006) Coronary flow reserve and heart failure in experimental coxsackievirus myocarditis. A transthoracic Doppler echocardiography study. Am J Physiol Heart Circ Physiol 291: H871-H875.
27. Galiuto L, De Caterina AR, Porfidia A, Paraggio L, Barchetta S, Locorotondo G, Rebuzzi AG, Crea F (2010) Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo syndrome. Eur Heart J 31: 1319-1327.
28. Sun H, Mohri M, Shimokawa H, Usui M, Urakami L, Takeshita A (2002) Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol 39(5): 847-851.
29. Ong P, Athanasiadis A, Mahrholdt H, Borgulya G, Sechtem U, Kaski JC (2012) Increased coronary vasoconstrictor response to acetylcholine in women with chest pain and normal coronary arteriograms (cardiac syndrome X). Clin Res Cardiol 101: 673-681.
30. Kitzman DW, Scholz DG, Hagen PT, Ilstrup DM, Edwards WD (1988) Age-related changes in normal human hearts during the first 10 decades of life. Part II (maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old. Mayo Clin Proc 63: 137-146.
31. Paulsen S, Vetner M, Hagerup LM (1975) Relationship between heart weight and the cross sectional area of the coronary ostia. Acta Pathol Microbiol Scand A 83: 429-432.
32. Knopp RH, Zhu X, Bonet B (1994) Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis 110 (Suppl): S83-S91.
33. The Writing Group for the PEPI Trial (1995) Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273: 199-208.
34. Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC (1993) The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Invest 23: 466-473.
35. Hirata K, Shimada K, Watanabe H, Muro T, Yoshiyama M, Takeuchi K, Hozumi T, Yoshikawa J (2001) Modulation of coronary flow velocity reserve by gender, menstrual cycle and hormone replacement therapy. J Am Coll Cardiol 38: 1879-1884.
36. Rosano GM, Peters NS, Lefroy D, Lindsay DC, Sarrel PM, Collins P, Poole-Wilson PA (1996) 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 28: 1500-1505.
37. Albertsson PA, Emanuelsson H, Milsom I (1996) Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X. Int J Cardiol 54: 13-20.
38. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA (1995) 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 92: 24-30.
39. Granger DN, Rodrigues SF, Yildirim A, Senchenkova EY (2010) Microvascular responses to cardiovascular risk factors. Microcirculation 17: 192-205.
40. Joshi MS, Tong L, Cook AC, Schanbacher BL, Huang H, Han B, Ayers LW, Bauer JA (2012) Increased myocardial prevalence of C-reactive protein in human coronary heart disease: direct effects on microvessel density and endothelial cell survival. Cardio Vasc Pathol 21: 428-435.
41. Teragawa H, Fukuda Y, Matsuda K, Ueda K, Higashi Y, Oshima T, Yoshizumi M, Chayama K (2004) Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart 90: 750-754.
42. Ong P, Sivanathan R, Borgulya G, Bizrah M, Iqbal Y, Andoh J, Gaze D, Kaski JC (2012) Obesity, inflammation and brachial artery flow-mediated dilatation: therapeutic targets in patients with microvascular angina (cardiac syndrome X). Cardiovasc Drugs Ther 26: 239-244.
43. Wong ND, Pio J, Valencia R, Thakal G (2001) Distribution of C-reactive protein and its relation to riskfactors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey (NHANES) III. Prev Cardiol 4: 109-114.
44. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98: 731-733.
45. Ridker PM, Buring JE, Cook NR, Rifai N (2003) C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14, 719 initially healthy American women. Circulation 107: 391-397.
46. Cook NR, Buring JE, Ridker PM (2006) The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 145(1): 21-29.
47. Marroquin OC, Kip KE, Kelley D et al (2004) The metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from WISE. Circulation 1009: 714-721.
48. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT (2009) The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J ClinEndocrinol Metab 82: 1293-1300.
49. De Rosa S, Cirillo P, Pacileo M, Di Palma V, Paglia A, Chiariello M (2009) Leptin stimulated C reactive protein production by human coronary artery endothelial cells. J Vasc Res 46: 609-617.
50. Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, Sopko G, Sharaf BM, Kelsey SF, Merz CN, Pepine CJ 2011 In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 162: 678-684.
51. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, Saito Y, SCAST (Statin and Coronary Artery Spasm Trial) Investigators (2008) Effects of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers. J Am Coll Cardiol 51: 1742-1748.
52. Aizawa T, Ogasawara K, Nakamura F, Hirosaka A, Sakuma T, Nagashima K, Kato K (1989) Effect of nicorandil on coronary spasm. Am J Cardiol 63: 75J-979.
53. Kaski JC, Valenzuela Garcia LF (2001) Therapeutic options for the management of patients with cardiac syndrome X. Eur Heart J. 22: 283-293.
54. Mehta PK, Goykhman P, Thomson LE, Shufelt C, Wei J, Yang Y, Gill E, Minissian M, Shaw LJ, Slomka PJ, Slivka M, Berman DS, BaireyMerz CN (2011) Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. JACC Cardiovasc Imaging 4: 514-522.
55. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA (1995) Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 25: 807-814.
56. Lamendola P, Lanza GA, Spinelli A, Sgueglia GA, Di Monaco A, Barone L, Sestito A, Crea F (2010) Long-term prognosis of patients with cardiac syndrome X. Int J Cardiol 140: 197-199.
57. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey SF, Arnsdorf MF, Black HR, Pepine CJ, Merz CN (2009) Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 169: 843-850.
58. Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, Madsen JK, Jørgensen E, Kelbæk H, Prescott E (2012) Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 33: 734-744.
59. Humphries KH, Pu A, Gao M, Carere RG, Pilote L (2008) Angina with "normal" coronary arteries: sex differences in outcomes. Am Heart J 155: 375-381.
60. Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, Rogers WJ, Mankad S, Sharaf BL, Bittner V, Bairey Merz CN (2006) Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 27: 1408-1415.
61. Shaw LJ, Merz CN, Pepine CJ, Reis SE, Bittner V, Kip KE, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Sopko G, Women's Ischemia Syndrome Evaluation (WISE) Investigators (2006) The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Circulation 114: 894-904.